Sort
85,873 grants matching “alzheimers”
Investigating the role of long-term latent herpes simplex virus infection on APOE4-associated Alzheimer's disease pathogenesis
$828,847Tal Nuriel · Columbia University Health Sciences · R01 · FY2024 · AG
Methodology Issues in a Tailored Light Treatment for Persons with Dementia
$828,802Mariana Gross Figueiro · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AG
Program of Intensive Support in Emergency Departments for Care Partners of Cognitively Impaired Patients (POISED-CPCIP)
$828,763Joshua Chodosh · New York University School Of Medicine · R01 · FY2017 · AG
CORE--CLINICAL
$828,754Christopher Michael Clark · University Of Pennsylvania · P30 · FY2010 · AG
Cognitive Resilience among Older Samoans
$828,732Becca R Levy · Yale University · R01 · FY2022 · AG
Study of Aging Latinas/os for Understanding Dementia in HIV (SALUD HIV)
$828,637Monica G Rivera-Mindt · Fordham University · R01 · FY2021 · AG
Targeting the miR-155 and APOE-TREM2 pathways to restore dysfunctional microglia in Alzheimerâs disease
$828,613Oleg Butovsky · Brigham And Women'S Hospital · R01 · FY2017 · AG
Stress, Weathering, and Blood-Based Biomarkers of Alzheimerâs Disease
$828,609Steven R Beach · University Of Georgia · R01 · FY2025 · AG
Direct protein phosphatase 2A (PP2A) activators as novel Alzheimerâs Disease (AD) therapeutics
$828,594Michael Ohlmeyer · Atux Iskay Group Llc · R44 · FY2025 · AG
Telehealth-Enhanced Patient-Oriented Recovery Trajectory After Intensive Care
$828,581Leanne M Boehm · Vanderbilt University · R01 · FY2023 · AG
Neuroimmune Genomic Profiling of Alzheimer's Disease
$828,534Evgeny I Rogaev · Univ Of Massachusetts Med Sch Worcester · U01 · FY2024 · AG
Presenilin and APP in the Brain
$828,365Jie Shen · Brigham And Women'S Hospital · R01 · FY2024 · NS
Presenilin and APP in the Brain
$828,365Jie Shen · Brigham And Women'S Hospital · R01 · FY2025 · NS
Development of GCPII inhibitors for the treatment of age-related cognitive disorders
$828,290Takashi Tsukamoto · Johns Hopkins University · R01 · FY2022 · AG
Targeting language-specific and executive-control networks with transcranial direct current stimulation in aphasic AD
$828,275Kyrana Tsapkini · Johns Hopkins University · R01 · FY2022 · AG
An Integrative Multi-Omics Approach to Elucidate Sex-Specific Differences in Alzheimers Disease
$828,195Marina Sirota · University Of California, San Francisco · R01 · FY2019 · AG
Alzheimer's Abeta, Tau, Apolipoproteins and Blood-brain barrier
$828,100Berislav V Zlokovic · University Of Southern California · R01 · FY2020 · NS
Harnessing Diverse BioInformatic Approaches to Repurpose Drugs for Alzheimers Disease
$828,046Mark W Albers · Massachusetts General Hospital · R01 · FY2018 · AG
Role of Lifespan Intervention on the Regulation and Progression of Alzheimer's Disease
$827,951Stacey J Rizzo · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AG
Intranasal delivery of VGF-derived peptides in a preclinical model of Alzheimer's disease
$827,826Stephen R Salton · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AG
MOTS-C, APOE, and Alzheimer's disease
$827,764Christian J Pike · University Of Southern California · R01 · FY2024 · AG
Molecular and Cellular Pathways Regulating Neurovascular Dysfunction in Degenerative Tauopathies
$827,748Lee E Goldstein · Boston University Medical Campus · R56 · FY2020 · AG
CSF Clearance in Sporadic Alzheimer's Disease
$827,746Yi Li · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · AG
Intervention for Hearing Health Among Native Americans
$827,727Oisaeng Hong · University Of California, San Francisco · R01 · FY2025 · NR
Routes to Enhanced HIV Neuropathogenesis Through Expression of Subclinical Levels of Endogenous Amyloid-Beta
$827,685David J Volsky · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · NS